tirzepatide for obesity fda approval Zepbound (tirzepatide) injection, the first and only treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Eli Lilly Gets FDA Approval

It is an experimental peptide with limited clinical evidence

This investment is one of the most significant milestones for Corxel since its founding as it not only fuels our effort to accelerate the global development of industry-leading therapies against cardiometabolic diseases but also propels the company to a new orbit of growth. Sandy Mou, CEO of Corxel, said at the time

If you have had a particularly demanding day or have been losing sleep, an evening dose can support these restorative pathways, which fits well within the Healthy Aging Supplements range

Of course, nothing is stopping you from trying it, stopping it if you dont like it, and still sending in those empty containers for your money back after the 60 days are up

Now, you need to encourage the powder to dissolve

Sources include: hpms-memos-wk-4-march-18-22, "Part D Coverage of Anti-Obesity Medications with Medically Accepted Indications", March 20, 2024